Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1984 3
1985 1
1986 1
1987 2
1988 4
1989 3
1990 4
1991 5
1992 8
1993 9
1994 10
1995 5
1996 2
1997 11
1998 7
1999 4
2000 5
2001 10
2002 6
2003 11
2004 6
2005 12
2006 9
2007 11
2008 8
2009 11
2010 10
2011 12
2012 14
2013 8
2014 8
2015 21
2016 16
2017 5
2018 4
2019 4
2020 6
2021 5
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

266 results
Results by year
Filters applied: . Clear all
Page 1
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Planchard D, Besse B, Groen HJM, Souquet PJ, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S, Rigas JR, Upalawanna A, D'Amelio AM Jr, Zhang P, Mookerjee B, Johnson BE. Planchard D, et al. Among authors: quoix e. Lancet Oncol. 2016 Jul;17(7):984-993. doi: 10.1016/S1470-2045(16)30146-2. Epub 2016 Jun 6. Lancet Oncol. 2016. PMID: 27283860 Free PMC article. Clinical Trial.
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis.
Planchard D, Besse B, Groen HJM, Hashemi SMS, Mazieres J, Kim TM, Quoix E, Souquet PJ, Barlesi F, Baik C, Villaruz LC, Kelly RJ, Zhang S, Tan M, Gasal E, Santarpia L, Johnson BE. Planchard D, et al. Among authors: quoix e. J Thorac Oncol. 2022 Jan;17(1):103-115. doi: 10.1016/j.jtho.2021.08.011. Epub 2021 Aug 26. J Thorac Oncol. 2022. PMID: 34455067 Free article. Clinical Trial.
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.
Planchard D, Kim TM, Mazieres J, Quoix E, Riely G, Barlesi F, Souquet PJ, Smit EF, Groen HJ, Kelly RJ, Cho BC, Socinski MA, Pandite L, Nase C, Ma B, D'Amelio A Jr, Mookerjee B, Curtis CM Jr, Johnson BE. Planchard D, et al. Among authors: quoix e. Lancet Oncol. 2016 May;17(5):642-50. doi: 10.1016/S1470-2045(16)00077-2. Epub 2016 Apr 11. Lancet Oncol. 2016. PMID: 27080216 Free PMC article. Clinical Trial.
Is there a role for e-cigarettes in smoking cessation?
Leduc C, Quoix E. Leduc C, et al. Among authors: quoix e. Ther Adv Respir Dis. 2016 Apr;10(2):130-5. doi: 10.1177/1753465815621233. Epub 2015 Dec 14. Ther Adv Respir Dis. 2016. PMID: 26668136 Free PMC article. Review.
[Recommendations of French specialists on screening for lung cancer].
Couraud S, Ferretti G, Milleron B, Cortot A, Girard N, Gounant V, Laurent F, Leleu O, Quoix E, Revel MP, Wislez M, Westeel V, Zalcman G, Scherpereel A, Khalil A. Couraud S, et al. Among authors: quoix e. Rev Mal Respir. 2021 Mar;38(3):310-325. doi: 10.1016/j.rmr.2021.02.003. Epub 2021 Feb 23. Rev Mal Respir. 2021. PMID: 33637394 French. No abstract available.
Comorbidities in the management of patients with lung cancer.
Leduc C, Antoni D, Charloux A, Falcoz PE, Quoix E. Leduc C, et al. Among authors: quoix e. Eur Respir J. 2017 Mar 29;49(3):1601721. doi: 10.1183/13993003.01721-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28356370 Free article. Review.
[Lung cancer and pollution].
Quoix E, Mennecier B. Quoix E, et al. Rev Pneumol Clin. 2003 Sep;59(4):187-95. Rev Pneumol Clin. 2003. PMID: 14699294 Review. French.
[Lung cancer in women].
Quoix E, Mennecier B. Quoix E, et al. Rev Mal Respir. 2005 Dec;22(6 Pt 2):8S55-62. Rev Mal Respir. 2005. PMID: 16340837 Review. French.
[Epidemiological novelties in lung cancer].
Quoix E, Lemarié E. Quoix E, et al. Rev Mal Respir. 2011 Oct;28(8):1048-58. doi: 10.1016/j.rmr.2010.12.015. Epub 2011 Nov 1. Rev Mal Respir. 2011. PMID: 22099410 Review. French.
266 results